Kaiser Permanente Institute for Health Policy

Institute for Health Policy

pill bottle

What is Kaiser Permanente’s different approach to prescription drugs?

At Kaiser Permanente we have different approach to prescription drugs that makes drugs better, safer and more affordable.

Publications

The Institute for Health Policy highlights approaches that can promote accessible, equitable, high-quality care and cultivate healthy communities. We partner with experts from a variety of backgrounds to identify, analyze, and discuss promising approaches.

What is Kaiser Permanente’s approach to value-based care?

Kaiser Permanente's approach to value-based care is a focus on evidence, simplicity, equity and alignment.

Coverage is essential for cancer detection and care

Health coverage is essential for cancer detection and care.

View all publications Get updates

All publications

Series: Medicare state issue briefs

Series: Medicaid state issue briefs

Series: Integrated Care Stories

Series: The Value of Coverage

Series: Research Round-Up

How should we address housing affordability to improve health?

How do we promote equitable outcomes for patients with high blood pressure?

How can interstate compacts expand access to mental health care?

What is Kaiser Permanente’s different approach to prescription drugs?

What is Kaiser Permanente’s approach to value-based care?

Coverage is essential for cancer detection and care

Focusing on equity in maternal health improves outcomes for everyone

Medicaid’s impact: healthier people, communities, and local economies

At a Glance: Kaiser Permanente’s participation in Medi-Cal (California)

Why the Enhanced Premium Tax Credits are important

Improving health – and health care – through environmental stewardship

Are biosimilar medications safe and effective?

IHP supported research on drug policy and value in 2024

Advancing public policies to support substance use disorder treatment and recovery

What are the applications and policy opportunities for AI in health care?

Telehealth insights from an integrated care system

Collaborative Care at Kaiser Permanente

Cultivating support: building mental health services that empower Black mothers

Delivering high-quality behavioral health care

Growing the mental health care workforce

Improving maternal health outcomes and advancing health equity

The growing role of tele-behavioral health in mental health care

Housing First is a matter of health

AHRQ funding improves health care quality: Congress should support it.

Research Roundup: Health care research summaries for policy leaders

Biosimilars at Kaiser Permanente: Lessons in successfully reducing spending on prescription drugs

How can leaders address the mental health workforce shortage?

Expanding the Mental Health Workforce in California

Feedback Informed Care

Turning the tide on the maternal health crisis

A farewell, but not goodbye, to our leader Murray Ross

It’s time to rethink health care quality measurement

Want to lower drug prices? Reform the U.S. patent system

Lawmakers must act to boost telehealth and digital equity

Policy Spotlight

Kaiser Permanente’s approach to strengthening small business

Want to lower drug prices? Reform the U.S. patent system

Preserving and bolstering the necessary tools to promote insulin affordability

Publications from PORTAL

Partner Spotlight: PharmedOut

Robust crisis response systems support mental health and prevent suicide

How pharmaceutical marketing affects decisions about patient care

A Conversation: Exploring Policy Opportunities in Nutrition Security and School Health

Partner Spotlight: PORTAL

From Tragedy to Transformation: Reforming Criminal Justice and the Mental Health System

What the pandemic taught us about public health

Restoring Provider Confidence In FDA-Approved Drugs

Evolving nature of evidence required by FDA to approve new drugs

Health care workforce needs and Kaiser Permanente’s approach

Beyond advocacy: Requiring vaccination to stop COVID-19

Creating tobacco-free communities

Applauding California’s ban on flavored tobacco

Maternity Care: How to Address Bias and Increase Cultural Humility

A Conversation: Unpacking Promising Food is Medicine Interventions & Supportive Policies

Drug policy 101: Kaiser Permanente’s approach to pharmaceutical detailing

Launching 988 nationally to support a continuum of care in mental health

Understanding the value of the Kaiser Permanente model

Improving mental health care for youth

Telehealth after the pandemic

Telehealth during the Covid-19 pandemic: Kaiser Permanente’s experience

Improved public health relies on stronger partnerships

Building a bigger table for a more equitable drug development system

Series: Drug policy 101

Drug policy 101: Pharmaceutical marketing tactics

Drug policy 101: Drug patents

Drug policy 101: Biosimilars

Drug policy 101: FDA risk evaluation and mitigation strategy (REMS)

Drug Policy 101: Pay-for-delay